X-ray information disclosure
This article was originally published in The Gray Sheet
Diagnostic X-ray manufacturers should not charge for design development or overhead when providing information on assembly, installation, adjustment and testing of X-ray system components to third parties as required under performance standards, Office of Compliance Director Timothy Ulatowski clarifies in letter to X-ray companies. Last month, the agency released a guidance on the matter entitled "1Information Disclosure by Manufacturers to Assemblers for Diagnostic X-Ray Systems"...
You may also be interested in...
Perrigo, Pfizer want the US FDA to postpone its March 1 deadline for conducting nitrosamine risk assessments. Generics exec cites“serious compliance challenges” in conducting these assessments due to difficulty in finding the right lab equipment necessary to quantify nitrosamine daily intake limits.
Deal snapshot: For $425m up front, the pharma obtains a Phase III recombination fusion protein that shows ability to improve hospitalized patients’ clinical status and reduce risk of death.
Previous businesses FDA warned about COVID-19 claims for chlorine dioxide, a bleach solution, were marketing dietary supplements unlawfully. But Pro Breath MD's oral rinses available under the Dentist Select and OraCare brands are allowed and FDA isn’t asking the firm to discontinue distribution.